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Monitoring seasonal influenza vaccination coverage
among pregnant women in the United States
Erin D. Kennedy, DVM, MPH; Indu B. Ahluwalia, MPH, PhD; Helen Ding, MD, MSPH;
Peng-Jun Lu, MD, PhD; James A. Singleton, PhD; Carolyn B. Bridges, MD
Pregnantwomen and their infants areat increased risk for serious influenza-
related complications, including prema-
ture labor, preterm birth, low birth-
weight, hospitalization, and maternal
and fetal death.1-9 Maternal influenza
vaccination has been shown to decrease
influenza-related illness in mothers and
to decrease the risk of influenza illness and
influenza-related hospitalization among in-
fants younger than 6months of age.4,5,8
Recommendations for influenza vacci-
nation of pregnant women have changed
over time. From 1966 to 1995, influenza
vaccination was recommended for preg-
nant women who had other medical
conditions that increased their risk for
influenza-related complications.10 The
Advisory Committee on Immunization
Practices (ACIP) encouraged vaccina-
tion of women in their third trimester of
pregnancy starting in the 1995-1996 in-
fluenza season and in 1997 recom-
mended vaccination for all women in
their second or third trimester of preg-
nancy.11,12 Because of the increased risk
for influenza-related complications, in
2004 ACIP recommended that all
women who are or will be pregnant dur-
ing an influenza season should be vacci-
nated, regardless of trimester.13
The Healthy People 2020 target for in-
fluenza vaccination coverage of pregnant
women is 80%. However, prior to the
2009 H1N1 pandemic, vaccination cov-
erage was typically below 20% as esti-
mated using the National Health Inter-
view Survey (NHIS).14,15 Historically,
influenza vaccination coverage among
pregnant women has been monitored
using the Behavioral Risk Factor Surveil-
lance System (BRFSS) and the NHIS.
The NHIS has provided important lon-
gitudinal data and national level esti-
mates, but the number of pregnant
women respondents is small and results
are typically delayed for more than a
year. BRFSS and NHIS respondents are
asked whether they have had an influ-
enza vaccination in the past 12 months
andwhether they were pregnant at inter-
view. The number of pregnant women
included in the NHIS is too small to re-
strict analysis to data from selected
months. Therefore, it is not possible to
restrict analysis of the NHIS to women
pregnant only during the influenza vac-
cination period. In 2012, the NHIS will
be modified to ascertain women who
were pregnant during the influenza sea-
son and whether influenza vaccination
occurred before, during, or after pregnan-
cy; therefore, in the future NHIS will be
able to provide more accurate estimates.
Since the 2009-2010 influenza season, 2
additional surveillance systems have been
used to monitor influenza vaccination
coverage among pregnant women: the
Pregnancy Risk Assessment Monitoring
System (PRAMS), which provides state-
level coverage, and Internet panel surveys,
which provide for rapid data collection
andanalyses andhave theflexibility to rap-
idly incorporate additional questions
about factors thatmay influence receipt of
vaccination. Coverage estimates and fac-
tors associated with maternal vaccination
are reviewed for Internet panel surveys of
pregnantwomenandPRAMS; new results
are reported from BRFSS and Internet
panel surveys. The strengths and limita-
tions of these 3 systems as well as the
characteristics of the NHIS are also
described.
Behavioral Risk Factor Surveillance
System (BRFSS), 2001-2011
Methods
The BRFSS is a collection of state-based,
random-digit, dialed telephone surveys
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This report describes surveillance systems used for assessing influenza vaccination coverage
among pregnant women in the United States. Coverage estimates and factors associated with
maternal vaccination are reviewed for internet panel surveys of pregnant women and the
Pregnancy Risk AssessmentMonitoring System (PRAMS); new estimates are reported from the
Behavioral Risk Factor Surveillance System (BRFSS) and Internet panel surveys. Influenza
vaccination coverage among pregnant women improved from 11% during the 2001-2002
influenza season to approximately 38% measured by BRFSS and 50% measured by Internet
panel surveys during the 2010-2011 influenza season. Coverage varied by state, ranging from
26% to 68% among the states participating in PRAMS in 2009-2010. Provider recommenda-
tion increased a woman’s likelihood of vaccination nearly 6-fold. Despite increases in influenza
vaccination coverage among pregnant women, approximately half remain unvaccinated. Con-
tinued efforts are needed to ensure pregnant women receive recommendations and offers of
vaccination from their health care providers.
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performed monthly in all 50 states and
the District of Columbia. The surveys
collect information from noninstitu-
tionalized adults on health risk behav-
iors, preventive health practices, health
care access, and chronic diseases (Table
1). The BRFSS sampling methodology
has been previously described.16 Ques-
tions about receipt of influenza vaccina-
tion have been on the core BRFSS ques-
tionnaire since January 2001.
Data from the 2001-2011 BRFSS were
analyzed by influenza season to compare
influenza vaccination coverage among
pregnant women 18-44 years of age with
nonpregnantwomenof the same age and
to identify trends over time. Influenza
vaccination status was assessed by asking
respondents whether they had a flu vac-
cine during the past 12 months. Preg-
nancy status was assessed in women
18-44 years of age by asking whether, to
their knowledge, they were pregnant at
the time of interview. To better approx-
imate womenwhowere pregnant during
an influenza season, we restricted analy-
ses to respondents interviewed Decem-
ber through February of a given season
(eg, for the 2010-2011 season, analysis
was restricted to respondents inter-
viewed during December 2010 through
February 2011).
To compare the coverage estimates
for pregnant womenwith nonpregnant
women, logistic regression with preg-
nancy status and age group (18-24, 25-
34, 35-44 years) as covariates was used
to calculate age-adjusted prevalence
ratios and 95% confidence intervals
(CIs). Tests for statistical significance
were set at alpha  0.05. The sample
size of pregnant women per state is too
small to calculate reliable coverage es-
timates; therefore, state-specific esti-
mates were not calculated.
Results
Among pregnant women aged 18-44
years of age, influenza vaccination cov-
erage increased from 11.2% (95% CI,
8.1–15.2%)during the 2001-2002 season
to 39.7% (95% CI, 31.7–48.2%) during
the 2010-2011 season (Figure). The
general pattern observed in influenza
vaccination coverage among pregnant
womenwas an increase in coverage from
the 2001-2002 season through the 2004-
2005 season, a plateau between the 2004-
2005 season and the 2007-2008 season,
and then an increasing trend through the
TABLE 1
Characteristics of surveys used to assess influenza vaccination
coverage among pregnant women in the United States
Variable BRFSS Internet panel surveys PRAMS NHIS
Recruitment method Stratified random-digit-dialing
sampling from commercial
landline and cellular telephone
databasesa
Nonprobability sampling from
a volunteer Internet panel
Stratified random sampling
from state birth certificate
registries
Complex sampling design
involving stratification,
clustering, and multistage
sampling
................................................................................................................................................................................................................................................................................................................................................................................
Survey mode Telephone interview Self-administered online Mailed survey with
telephone follow-up
Face-to-face interview
................................................................................................................................................................................................................................................................................................................................................................................
Timing of pregnancy At interview (use December-
February interviews)
At interview or since August 1
of corresponding influenza
season
Had a live birth within past
2–6 months
At interview
................................................................................................................................................................................................................................................................................................................................................................................
Timing of influenza
vaccination
Within past 12 mo (since 2008
can determine whether during
influenza season)
During influenza season During influenza season Within past 12 months
(since 2005 can
determine whether during
influenza season)
................................................................................................................................................................................................................................................................................................................................................................................
Geographic level Nationalb National State or localc National
................................................................................................................................................................................................................................................................................................................................................................................
Data collection
schedule
Monthly Twice during influenza season
(November and April)
Ongoing Monthly
................................................................................................................................................................................................................................................................................................................................................................................
Timeliness of
reporting
Within 2 mo Two wks Within 18 mo Within 18 mo
................................................................................................................................................................................................................................................................................................................................................................................
Typical response/
completion rated
55% 90% 65% 61%
................................................................................................................................................................................................................................................................................................................................................................................
Approximate sample
size of pregnant
women
400–800 per season using
December-February interviews
1500 per survey 300–1500 per state/city 55–65 per influenza
season using
December-February
interviews
................................................................................................................................................................................................................................................................................................................................................................................
BRFSS, Behavioral Risk Factor Surveillance System; NHIS, National Health Interview Survey; PRAMS, Pregnancy Risk Assessment Monitoring System.
a Cellular telephones were added to BRFSS in 2011; b The BRFSS is a collection of state-based random-digit dialed telephone surveys that can be combined to calculate national estimates; c PRAMS
surveys are currently administered by 37 states, New York City, and 1 tribal-state partnership, the South Dakota Tribal Project; 29 states and New York City included the influenza supplement during
the 2009–2010 influenza season; d Completion rate reported for Internet panel surveys, which is defined as percent of those who complete the survey among those who volunteer to participate and
are eligible for the survey; response rate was reported for BRFSS, PRAMS, and NHIS. Response rate for BRFSS is state median for 2010. Response rate for NHIS is from 2010. Response/completion
rates may not be directly comparable.
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2010-2011 season (Figure). Influenza
vaccination coverage among pregnant
women increased from 26.9% (95% CI,
20.6–34.3) during the 2007-2008 season
to 34.9% (95%CI, 29.2–41.0) during the
2008-2009 season to 38.0% (95% CI,
31.7–44.7) during the 2009-2010 season
and 39.7% (95% CI, 31.7–48.2) during
the 2010-2011 season. During the 2001-
2002 influenza season, vaccination cover-
age among pregnant women was lower
when compared with coverage among
nonpregnantwomen (age-adjustedpreva-
lence ratio 0.7, 95%CI, 0.5–1.0). Vaccina-
tion coverage was statistically significantly
higher amongpregnantwomencompared
with nonpregnant women in the 2004-
2005 season (age-adjustedprevalence ratio
2.3, 95% CI, 1.9–2.9) when an influenza
vaccine shortage occurred and pregnant
women and others at increased risk of se-
vere influenza were prioritized for avail-
able vaccine and remained higher during
the 2005-2006 season (age-adjusted prev-
alence ratio 1.5, 95% CI, 1.2–1.8).17 Cov-
erage was also significantly higher among
pregnant women during the 2008-2009
(age-adjustedprevalenceratio1.3,95%CI,
1.1–1.5), 2009-2010 (age-adjusted preva-
lence ratio 1.3, 95% CI, 1.1–1.5), and
2010-11 (age-adjusted prevalence ratio
1.4, 95%CI, 1.1–1.7) seasons.
Summary
The BRFSS is a useful tool for examining
national trends in influenza vaccination
coverage among pregnant women over
time, as well as comparing influenza vac-
cination coverage of pregnant and non-
pregnant women. However, the results
from BRFSS are subject to limitations.
First, self-reported influenza vaccination
status is subject to recall bias, although
studies of adults have shown self-report
of influenza vaccination status to be
fairly sensitive and specific.18 Second, as
for all such population-based surveys,
nonresponse and noncoverage bias may
remain after weighting adjustments.
Third, in our evaluation of the role of
pregnancy as an indication for vaccina-
tion, we controlled for age but did not
control for other potential confounders
such as socioeconomic status or exis-
tence of other high-risk medical condi-
tions. Fourth, although restricting the
analysis to women currently pregnant
December-February for each season en-
sured that all women classified as preg-
nant were pregnant at some time during
the influenza season, women who were
pregnant at other times during the influ-
enza season but not at the time of their
interviewmay have been misclassified as
nonpregnant. Although this may not
bias estimates of vaccination coverage of
pregnant women, it would tend to atten-
uate prevalence ratios comparing preg-
nant to nonpregnant women toward
one. The approximate sensitivity of us-
ing women pregnant when interviewed
during December-February is estimated
to be 78% (11 of 14 monthly birth co-
horts with pregnancy sometime during
September-February would be captured
by women pregnant December-Febru-
ary). Vaccination coverage estimates for
pregnant and nonpregnant women will
be underestimated if they were vacci-
nated after the date of their interview in
December-February. However, this is
unlikely because most vaccinations typi-
cally occur by the end of November.19
Internet panel surveys, 2010-2011
and 2011-2012 seasons
Methods
Internet panel surveys were conducted
during the 2010-2011 and 2011-2012 in-
fluenza seasons to provide rapidmidsea-
son and end-of-season estimates of na-
tional influenza vaccination coverage
among pregnant women and to assess
factors associated with receipt of vacci-
nation (Table 1). Women aged 18-49
years who were pregnant at any time
FIGURE
Influenza vaccination coverage in pregnant and
nonpregnant women by influenza season
Influenza vaccination coverage (unadjusted) among pregnant and nonpregnant women 18-44 years
old by influenza season in the United States, Behavioral Risk Factor Surveillance System, 2001-2011.
Each season includes women interviewed during December through February (eg, for the 2010-2011
season, analysis was restricted to respondents interviewed during December 2010 through February
2011). Asterisk indicates coverage estimates among pregnant women are statistically significantly
different (P .05) compared with estimates for nonpregnant women during the same season based
on age-adjusted prevalence ratio from logistic regression model of influenza vaccination status with
pregnancy status and age group as independent variables.
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since August 1, 2010, were recruited
from the SurveySpot panel operated by
Survey Sampling International. Two
methods were used to recruit the preg-
nant women panelist for this survey.
First, a message advertising the survey
was placed on the main panel web site,
inviting panelists to view the survey eli-
gibility questions on the panel’s require-
ment page. Second, an e-mail invitation
was sent to a sample of panelists whose
panel profiles indicated that they were
women aged 18-49 years living in the
United States, and interested panel
members went to the panel’s require-
ment page to answer the survey eligibility
questions.20
Midseason surveys were conducted
November 11-22, 2010, and November
1-14, 2011. The 2010-2011 end-of-sea-
son surveys were conducted April 4-25,
2011; the end-of season survey for the
2011-2012 season is planned for April
2012. Influenza vaccination status was
assessed by asking respondents whether
they had an influenza vaccination since
August 1. Pregnancy status questions in-
cluded whether respondents were cur-
rently pregnant or pregnant at any time
since August 1. All respondents were
asked whether they had seen a doctor or
other medical professional since August;
those answering “yes” were asked whether
their doctor or other medical professional
had recommended or offered them an in-
fluenza vaccination since August.
The analysis of the April 2011 data was
restricted to women reporting that they
were pregnant at any time fromOctober
1, 2010, through January 31, 2011; No-
vember 2010 andNovember 2011 results
include women pregnant at any time
from August 1 through their November
interview date of the corresponding sur-
vey year. Samples were weighted to re-
flect the age and race/ethnicity distribu-
tion based on census region estimates
from the US population of pregnant
women.21 The Internet panel surveys
were determined by Centers for Disease
Control and Prevention (CDC) to be
public health nonresearch.
Results
From the November 2010 survey, 44.8%
(95% CI, 41.8–47.8%) of 1396 women
reported being vaccinated as of mid-No-
vember 2010; an additional 4.5% indi-
cated that they definitely intended to get
vaccinated during the 2010-2011 influ-
enza season.22 The combined estimate of
49.3% of already vaccinated plus those
with a definite intent was very similar to
the final 2010-2011 Internet panel vacci-
nation coverage estimate of 49.0% (95%
CI, 46.2–51.7%).20 Mid-season esti-
mates for the 2011-2012 season from the
November 2011 survey indicated that
vaccination coverage among pregnant
women was similar compared with the
same time during the 2010-2011 season
(43.2%vs 44.8%), indicating that vaccina-
tion coverage among pregnant women for
the 2011-2012 season will likely remain
similar to the 49% coverage obtained dur-
ing the 2010-2011 season.23
During the 2010-2011 season, women
who reported receiving a provider rec-
ommendation for influenza vaccination
were nearly 6 times as likely to report
vaccination as those who reported not
receiving a provider recommendation
(68.8% vs 11.7%). Among respondents
receiving a recommendation for influ-
enza vaccination, those receiving an of-
fer were more than twice as likely to be
vaccinated as those who reported no of-
fer (74.5% vs 33.5%). Similar results re-
garding both recommendation and offer
were seen in the midseason survey con-
ducted in November of the 2011-2012
season.23 Women who received an offer
of influenza vaccination from a heath
care provider were more likely to believe
influenza vaccineswere effective and safe
for themselves and their infants when
compared with women who did not re-
ceive such an offer.20 During the 2010-
2011 season, the most common place of
influenzavaccination forpregnantwomen
was an obstetrician-gynecologist or mid-
wife’s office (61%) followed by another
doctor’s office or medically related place
(22%).20 An obstetrician-gynecologist or
midwife’s office was also the most com-
mon place of vaccination reported in the
November 2011 survey.23
Summary
Internet panel surveys are a useful sur-
veillance tool for timely nationalmidsea-
son and end-of-season estimates of in-
fluenza vaccination coverage among
pregnant women with results available
within 4 weeks of collection. These panel
surveys also allow for additional influ-
enza vaccination-related questions ad-
dressing the knowledge, attitudes, and
practices of pregnant women. However,
the surveys are conducted among a vol-
unteer panel, all of whom must have ac-
cess to the Internet, thus, resultsmay not
be representative of all pregnant women
in the United States. Additionally, all re-
sults are based on self-report without
medical record verification and are sub-
ject to recall bias. Persons receiving vac-
cination may be more likely to recall re-
ceiving a provider recommendation or
offer. Therefore, prevalence ratios for
vaccination by provider recommenda-
tion or offer may be overestimated.
Pregnancy Risk Assessment
Monitoring Systems (PRAMS),
2009-2010 influenza season
Methods
PRAMS is an ongoing, population-based
survey that collects data on a wide range
of maternal behaviors and experiences
before, during, and after pregnancy
among women who recently delivered a
live-born infant (Table 2). PRAMS sur-
veys are currently administered by 37
states, New York City, and 1 tribal-state
partnership, the South Dakota Tribal
Project. The surveys consist of monthly
stratified random samples of 100-300
women per state/city with recent live-
born infants sampled from state birth
certificate registries. The selected moth-
ers are mailed a questionnaire 2-6
months after delivery, and those who do
not respond by mail are contacted by
telephone. The PRAMS sampling meth-
odology has been previously described.24
Supplemental questions were added to
the PRAMS survey during the 2009-10
influenza season; 29 states andNewYork
City participated in the supplement.
Data from the PRAMS influenza vacci-
nation supplement were analyzed to as-
sess state-specific seasonal influenza
vaccination coverage among pregnant
women who had live births from Sep-
tember 2009 to May 2010. Seasonal in-
fluenza vaccination status was deter-
mined by asking respondents whether
Supplement www.AJOG.org
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they received a seasonal flu shot since
September 2009.
Results
The estimated median seasonal influ-
enza vaccination coverage was 47.1% in
the 29 states plus New York City in-
cluded in PRAMS during the 2009-2010
influenza season.25 Coverage varied by
state, ranging from 26.1% in Florida to
67.9% in Minnesota (Table 2).25 Data
from the 2010-2011 influenza season are
pending.
Summary
PRAMS is the only state-specific data
source to assess influenza vaccination
coverage among women with live-born
infants and allows for comparisons of
vaccination coverage across participat-
ing states. The PRAMS survey uses the
birth files for sampling women with live
births, which can take several months
and is primarily a mail survey with
phone follow-up of nonresponders by
mail. Therefore, it may be less flexible
than the Internet panel survey, which
can be changed in a very short period of
time. However, it was possible to add
supplemental questions during the 2009
H1N1pandemic response to the PRAMS
survey.
PRAMS data also have some limita-
tions. First, results are not available until
approximately 18 months after the end
of the influenza season. Second, results
may not be generalizable to the entire
United States or to women whose preg-
nancy does not end in a live birth. Addi-
tionally, the women included in this
analysis represent only a subset of
women who were pregnant during the
periods when seasonal influenza vac-
cines were available during the 2009-
2010 season. Influenza vaccination sta-
tus was self-reported and may be subject
to recall bias.
Comment
Influenza vaccination coverage among
pregnant women has increased substan-
tially since the 2001-2002 season, when
coverage was significantly lower among
pregnant women when compared with
nonpregnant women. Although multi-
TABLE 2
State-specific seasonal influenza vaccination coverage among
women with live births, PRAMS, 2009–2010 influenza seasona
State n %b 95% CI
Arkansas 1055 46.7 4.1
..............................................................................................................................................................................................................................................
Colorado 1317 52.8 3.8
..............................................................................................................................................................................................................................................
Florida 927 26.1 3.3
..............................................................................................................................................................................................................................................
Georgia 614 29.9 5.6
..............................................................................................................................................................................................................................................
Hawaii 974 50.3 4.0
..............................................................................................................................................................................................................................................
Illinois 1071 47.1 3.2
..............................................................................................................................................................................................................................................
Louisiana 540 39.6 5.2
..............................................................................................................................................................................................................................................
Maine 709 64.0 4.0
..............................................................................................................................................................................................................................................
Maryland 1080 46.1 4.5
..............................................................................................................................................................................................................................................
Massachusetts 996 67.5 4.0
..............................................................................................................................................................................................................................................
Michigan 1000 44.7 3.6
..............................................................................................................................................................................................................................................
Minnesota 917 67.9 3.3
..............................................................................................................................................................................................................................................
Mississippi 862 37.2 4.0
..............................................................................................................................................................................................................................................
Missouri 973 42.8 3.7
..............................................................................................................................................................................................................................................
Nebraska 1198 65.4 3.2
..............................................................................................................................................................................................................................................
New Jersey 1053 36.8 3.2
..............................................................................................................................................................................................................................................
New York 1587 50.5 3.1
..............................................................................................................................................................................................................................................
New York City (NYC) 894 45.9 4.1
..............................................................................................................................................................................................................................................
New York without NYC 693 54.7 4.7
..............................................................................................................................................................................................................................................
Ohio 829 42.7 4.5
..............................................................................................................................................................................................................................................
Oklahoma 1432 49.1 4.4
..............................................................................................................................................................................................................................................
Rhode Island 821 63.7 3.9
..............................................................................................................................................................................................................................................
South Carolina 676 45.3 6.5
..............................................................................................................................................................................................................................................
Tennessee 650 41.2 5.1
..............................................................................................................................................................................................................................................
Texas 898 44.9 4.1
..............................................................................................................................................................................................................................................
Utah 1124 57.8 3.2
..............................................................................................................................................................................................................................................
Vermont 742 66.3 3.4
..............................................................................................................................................................................................................................................
Virginia 318 51.2 7.3
..............................................................................................................................................................................................................................................
Washington 1052 53.3 4.0
..............................................................................................................................................................................................................................................
West Virginia 1121 44.2 3.6
..............................................................................................................................................................................................................................................
Wyoming 617 55.6 4.6
..............................................................................................................................................................................................................................................
Median 973 47.1
..............................................................................................................................................................................................................................................
Minimum 318 26.1
..............................................................................................................................................................................................................................................
Maximum 1587 67.9
..............................................................................................................................................................................................................................................
n 27,153.
PRAMS, Pregnancy Risk Assessment Monitoring System.
a Women with live births between September 1, 2009, and May 31, 2010, with nonmissing seasonal influenza vaccination status;
b Weighted to adjust for complex survey design and nonresponse.
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ple surveys indicate an increase in cover-
age, 1 in 2 pregnant women remain un-
vaccinated against influenza. Increasing
recommendations and offers for influ-
enza vaccination by providers of preg-
nant women stands to have a substantial
impact on the acceptance of influenza vac-
cination by pregnant women. Efforts
should continue to monitor the influenza
vaccination rates of pregnant women and
to increase the number of providers rou-
tinely recommending and offering annual
influenza immunization of their pregnant
patients.
Assessing influenza vaccination cover-
age among pregnant women is complex
because of the fact that pregnant women
account for only about 1% of the popu-
lation and the need to assess both preg-
nancy and influenza vaccination status
during a given influenza season.26 Each
data collection systemdescribeduses dif-
ferent methodologies and has its own
strengths and limitations (Table 1).
The BRFSS has been conducted since
1984, and questions regarding influenza
vaccination status have been on the core
questionnaire since January 2001. Given
the length of time influenza vaccination
questions have been on the core BRFSS
questionnaire, sufficient BRFSS sample
size to allow ascertainment of women
pregnant during an influenza season that
has a high positive predictive value, and
that other sources of national-level data
on vaccination coverage in pregnant
women have at most 2 years of data, the
BRFSS is currently the best available tool
to examine national trends in vaccina-
tion coverage among pregnant women
over time and to utilize to compare with
trends in coverage based on other sources
of data. Because theBRFSS targets the gen-
eral population with a wide range of ques-
tions about health, the BRFSS can be used
to compare vaccination coverage of preg-
nant women with that of nonpregnant
women or other high-risk groups. How-
ever, the BRFSS includes relatively low
numbers of pregnant women per state,
precluding seasonal state-based estimates.
Another limitation of the BRFSS in assess-
ingcoverage inpregnantwomen is that the
pregnancy status is determined at the time
of interview; therefore, women who were
pregnant at other times during the influ-
enza season but not at the time of their in-
terview may have been misclassified as
nonpregnant.
The Internet panel surveys described
in this report are designed to provide
timely midseason and end-of-season es-
timates of influenza vaccination cover-
age among pregnant women. Strengths
of these surveys include that the entire
cohort of women pregnant during the in-
fluenza season are potentially eligible for
participation, and the timing of influenza
vaccination relative to pregnancy is as-
certained. Results from the Internet
panel survey produce estimates similar
to those obtained through BRFSS.20
However, the Internet panel surveys
have been conducted only since the
2010-2011 season and are not able to ex-
amine trends over a longer period of
time, nor can the survey compare vacci-
nation coverage of pregnant women
with other groups. The Internet panel is
also useful in assessing the knowledge,
attitudes, and practices of pregnant
women nationally and has flexibility for
the addition or modification of ques-
tions before each survey.
PRAMS is the only state-specific data
source available to assess influenza vac-
cination coverage among women with
live-born infants. Providing state-spe-
cific results enables immunization pro-
grams to assess the effectiveness of their
current efforts to vaccinate pregnant
women and to modify their programs
based on these results. However, because
not all states are included in PRAMS,
these data cannot be used to estimate na-
tional-level coverage. A further limita-
tion is the timeliness of the data, with
results for the 2011-12 data not expected
to become available until mid-2013.
A potential limitation of all surveys
used to estimate influenza vaccination
coverage during the 2009-2010 influenza
season is that estimates of vaccination
coverage for seasonal influenza may be
less reliable than estimates from other
years because of the potential for less ac-
curate recall regarding receipt of sea-
sonal versus 2009 H1N1 vaccine.
Each data collection system described
here has its individual strengths; exami-
nation of results fromall 3 surveys is nec-
essary to fully assess influenza vaccina-
tion coverage among pregnant women
in theUnited States. Starting in 2012, the
NHIS will ask whether women 18-49
years of age were pregnant anytime dur-
ing August through March; for women
reporting receipt of influenza vaccina-
tion, it will ask whether they were vacci-
nated before, during, or after pregnancy.
Given the more complete sample frame
and higher response rates of the NHIS
(60.8%), thismay provide another check
on the validity of estimates and trends
from BRFSS, PRAMS, and Internet
panel surveys.27
In 2008, the CDC convened a meeting
of experts and key partners that focused
on special considerations for pregnant
women in the event of an influenza pan-
demic; improving uptake of seasonal in-
fluenza vaccination by pregnant women
was recognized as a key factor that could
improve uptake of influenza vaccination
in the event of a pandemic.28 During the
2009 H1N1 influenza pandemic, the
CDC, the American College of Obstetri-
cians andGynecologists, andotherpartner
organizations emphasized the risk of se-
vere complications for pregnant women
and their infants from both seasonal and
2009 H1N1 influenza, encouraging preg-
nant women to get vaccinated and pro-
moting the role of obstetricians and gyne-
cologists as vaccinators.1,26,29,30
In response to the 2009 H1N1 pan-
demic and efforts over prior years, vacci-
nation rates have increased markedly
over the past decade to a high of 39.7%
during the 2010-2011 season, as mea-
sured by BRFSS, and 49% for the same
season, as measured by the Internet
panel survey.Although it appears thatwe
have sustained the increased coverage
rates among pregnant women seen dur-
ing the 2009 H1N1 pandemic, coverage
still remains far below theHealthy People
2020 target of 80%.
Common reasons reported by preg-
nant women for not receiving influenza
vaccinationduring the 2010-2011 season
include concerns about safety risks to
themselves and their infants, side effects,
and effectiveness of the vaccine.20
A study of postpartum women con-
ducted in 1 health care facility found that
the 3 main reasons participants did not
receive the vaccine were the belief that
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the vaccine was not safe in pregnancy,
the vaccine was not available in their ob-
stetrician’s office, and the vaccine was
not offered to them.31
Results from the Internet panel survey
described in this report indicate that
pregnant women who received a recom-
mendation for influenza vaccination are
nearly 6 times as likely to report being
vaccinated; among those receiving a rec-
ommendation, women who received an
offer were twice as likely to be vaccinated
when compared with women who had
not received an offer. Additionally,
women who receive an offer are more
likely to believe influenza vaccination is
effective and safe.
Additional efforts to increase provider
recommendation and offer of influenza
vaccination to pregnant patients are
likely to have substantial impacts on in-
fluenza vaccination uptake in pregnant
women. However, many barriers to ob-
stetric providers offering influenza vacci-
nation in their offices have been identified,
including absence of appropriate storage
and handling facilities, limited existing in-
frastructure andprocedures in their offices
for offering vaccines, and concerns about
inadequate reimbursement.32-35
Reducing these barriers and increasing
awareness among patients and providers
about the benefits of influenza vaccina-
tion for both mother and infant are crit-
ical to further expand the uptake of in-
fluenza vaccination by pregnant women
and to reduce severe illness from influ-
enza in both mothers and infants. f
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